Live Breaking News & Updates on Pennsylvania Based Arrivent
Stay updated with breaking news from Pennsylvania based arrivent. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ArriVent BioPharma will apply the IPO cash toward furmonertinib, which the biotech says could offer advantages over Takeda Pharmaceutical and Johnson & Johnson drugs that address the same lung cancer target. It’s the second biotech IPO of this week, following CG Oncology. ....
After a $3B exit, a biopharma veteran unveils a new company and a global focus medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.